Skip to main content

Controlling Motor Symptoms of Advanced Parkinson's

This resent research is important because it brings forth new and significant light into the treatment for those who suffer from Parkinson's disease. Parkinson's affects around 1 million people in the U.S. Doctors diagnose up to 60,000 new cases each year. Those with Parkinson's disease suffer from dyskinesias. It is one of the most common symptoms to occur to those who have it. Dyskinesias means, abnormality or impairment of voluntary movement. Neuroscientists assume dyskinesias come from fluctuations in dopamine. The drug that is usually used to restore dopamine levels is levodopa. The problem with levodopa is that sometimes dopamine levels become too high, and results are unstable and treatment for dyskinesias is unsafe. A team of researchers tested two drugs on whether the drug LY235959 (an NMDA receptor antagonist) or NBQX (an AMPA receptor antagonist) could calm hyperactivity and dyskinesia symptoms in Parkinson's model monkeys. Both drugs lowered the SPN firing frequency of levodopa by 50 percent. The results show dopamine levels stabilize and abnormal movements are merely diminished. The drugs aren't yet safe for human consumption but this new research adds more light and more insight for helping those with Parkinson's disease. With more and more research happening daily on this disease we hope that those that suffer can one day live a life with the ability to control the symptoms of dyskinesias.


 http://news.emory.edu/stories/2018/01/papa_parkinsons_dyskinesiamech/


Comments

  1. UnknownMarch 27, 2018 at 7:54 AM

    I wonder how the two drugs LY235959 (an NMDA receptor antagonist) or NBQX (an AMPA receptor antagonist) effect the individuals tested on a molecular level? Possibly by knowing how the drugs work we can see why they are unsafe for humans and hopefully change them in a way to where it is possible to use them to treat humans.

    ReplyDelete

Post a Comment

Popular posts from this blog

Household chemicals rival vehicles as smog source- Sarah Quist

Household chemicals rival vehicles as smog source Sarah Quist BIOL 1610 2/17/18 This article was of particular interest to me as I have been keenly aware, for many years now, the dangers of toxic household products, personal products and chemicals used on lawns and gardens. Although regulations have made some progress in reducing vehicle emissions, smog remains a huge problem in US cities. A group of researchers set out to find what other sources could be contributing to the continuation of polluted air. The research was led by Brian McDonald, an air-pollution researcher at the US National Oceanic and Atmospheric Administration (NOAA) in Bolder, Colorado. Brian stated that he was surprised to find that the products he used in the morning to get ready for work are comparable to the emissions coming from the tailpipe of his car. What they found was that chemical products are different than vehicle emissions in that they are designed to evaporate. "Once in the air, the compoun...
Post a Comment
Read more

Getting the Inside Dope on Ketamine’s Mysterious Ability to Rapidly Relieve Depression

In the article Getting the Inside Dope on Ketamine’s Mysterious Ability to Rapidly Relieve Depression by Simon Makin, he opens with, “Ketamine has been called the biggest thing to happen to psychiatry in 50 years…” The article discusses how researches don’t yet completely understand how the drug Ketamine can improve depression symptoms in as little as 30 minutes, but other known anti-depressants take weeks or even months. The article goes on about how ketamine early on started being abused like most drugs and it is known to cause hallucinations, out-of-body experiences and other effects and its anti-depressant properties weren’t discovered until about 20 years later. Researchers have found that ketamine does not influence mood like other ant-depressants, but it actually affects the brain by blocking depression from entering the lateral habenula (LHb). LHb is what activates when your expectations are not met or you are disappointed. Tests were ran on lab rats that showed depre...
1 comment
Read more